Inventor · disambiguated record
Patrick J. Lupardus
Also filed as: LUPARDUS PATRICK · LUPARDUS PATRICK J
24 granted patents·34 pending applications·49 citations·filing 2010–2025
93Inventor score
Top patents by PatentIndex Score
58 records- 0195US11873349B1Compositions and methods related to IL27 receptor bindingSYNTHEKINE INC·Filed 2023·Granted Jan 16, 2024·3 cites·6 claims
- 0295US10017572B2Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2016·Granted Jul 10, 2018·19 cites·22 claims
- 0394US12103954B2Heterodimeric Fc cytokines and uses thereofSYNTHEKINE INC·Filed 2024·Granted Oct 1, 2024·2 cites·15 claims
- 0494US10047158B2Anti-TIGIT antibodies and methods of useGENENTECH INC·Filed 2018·Granted Aug 14, 2018·13 cites·30 claims
- 0593US11859001B2IL12RB1-Binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Jan 2, 2024·2 cites·14 claims
- 0691US12077594B2IL2RG binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Sep 3, 2024·3 cites·22 claims
- 0788US12012457B1IL23R binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Jun 18, 2024·1 cites·42 claims
- 0887US12291572B2IL12 receptor synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Granted May 6, 2025·1 cites·12 claims
- 0987US12157773B2IL27RAlpha binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Dec 3, 2024·1 cites·53 claims
- 1086US12297281B2IL10RA binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted May 13, 2025·1 cites·16 claims
- 1184US2024117037A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 1284US2023279102A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2022·Application pending·0 cites
- 1379US2025340656A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 1479US2025376528A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 1578US2025326837A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 1678US2024376217A1Il23r binding molecules and methods of useSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 1777US2024418731A1Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic informationGENENTECH INC·Filed 2024·Application pending·0 cites
- 1877US2022064286A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 1976US9284365B2Anti-hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2013·Granted Mar 15, 2016·2 cites·12 claims
- 2075US12209132B2Compositions and methods related to IL27 receptor bindingSYNTHEKINE INC·Filed 2023·Granted Jan 28, 2025·0 cites·19 claims
- 2175US2025019453A1Il2rb/il2g synthetic cytokinesSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 2275US2021253693A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 2375US2024166754A1Il12rb1-binding molecules and methods of useSYNTHEKINE INC·Filed 2023·Application pending·0 cites
- 2475US2025171548A1IL27RAlpha BINDING MOLECULES AND METHODS OF USESYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 2575US2025163167A1Il10 receptor binding molecules and methods of useSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 2672US12139545B2IL10 receptor binding molecules and methods of useSYNTHEKINE INC·Filed 2023·Granted Nov 12, 2024·0 cites·15 claims
- 2772US2021032328A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2020·Application pending·0 cites
- 2871US12286482B2IL10RB binding molecules and encoding nucleic acidsSYNTHEKINE INC·Filed 2021·Granted Apr 29, 2025·0 cites·13 claims
- 2970US2024279322A1Isoform-selective anti-tgf-beta antibodies and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 3069US2024026014A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3169US2025179198A1Compositions and methods related to il27 receptor bindingSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 3268US10564165B2Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic informationGENENTECH INC·Filed 2015·Granted Feb 18, 2020·1 cites·11 claims
- 3367US12018085B2Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodies and method of use thereof to treat autoimmune and inflammatory diseasesSYNTHEKINE INC·Filed 2021·Granted Jun 25, 2024·0 cites·109 claims
- 3467US2025333521A1Il10rb binding molecules and encoding nucleic acidsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 3566US2019119376A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2018·Application pending·0 cites
- 3663US12372533B2Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic informationGENENTECH INC·Filed 2020·Granted Jul 29, 2025·0 cites·9 claims
- 3763US11919948B2Isoform-selective anti-TGFβ antibodies and methods of useGENENTECH INC·Filed 2021·Granted Mar 5, 2024·0 cites·27 claims
- 3863US9067979B2Anti-hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2014·Granted Jun 30, 2015·0 cites·13 claims
- 3963US2023272094A1Il2rb/il2rg synthetic cytokinesSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4059US12448457B2GP130 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Oct 21, 2025·0 cites·20 claims
- 4159US2023279126A1Il23 receptor synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4259US2023279125A1Il28ra binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4359US2023391891A1Il28a receptor binding synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4459US2023365696A1Ifngr1 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4558US2025333520A1Compositions and methods related to il2 receptor bindingSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 4658US2019023770A1Anti-hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2018·Application pending·0 cites
- 4758US2023357414A1Il12rb2 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4856US12122839B2IFNGR binding synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Granted Oct 22, 2024·0 cites·14 claims
- 4956US9908931B2Anti-hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2016·Granted Mar 6, 2018·0 cites·19 claims
- 5056US2023357424A1Cd45 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Patrick J. Lupardus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →